Pomalidomide-based regimens bridging CAR-T therapy in multiple myeloma with central nervous system involvement

Qiqi Zhang; Cheng Zu; Fang Ni; Zhe Yang; Zhiye Zhang; Mingming Zhang; He Huang; Yongxian Hu

doi:10.1016/j.reth.2022.05.007

Pomalidomide-based regimens bridging CAR-T therapy in multiple myeloma with central nervous system involvement

Regen Ther. 2022 May 31:21:34-36. doi: 10.1016/j.reth.2022.05.007. eCollection 2022 Dec.

Authors

Qiqi Zhang^{1

2

3

4}, Cheng Zu^{1

2

3

4}, Fang Ni^{1

2

3

4}, Zhe Yang⁵, Zhiye Zhang⁶, Mingming Zhang^{1

2

3

4}, He Huang^{1

2

3

4}, Yongxian Hu^{1

2

3

4}

Affiliations

¹ Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, China.
² Liangzhu Laboratory, Zhejiang University Medical Center, China.
³ Institute of Hematology, Zhejiang University, China.
⁴ Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, China.
⁵ Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, China.
⁶ Fuyang Hospital Affiliated to Anhui Medical University, China.

No abstract available